Carlos A. Zarate

Also affiliated with National Institute of Mental Health, National Institute of Mental Health

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The association between variability, intensity, and persistence of suicidal ideation and prospective suicidal behavior in the systematic treatment enhancement program for bipolar disorder (STEP-BD) study

International Journal of Bipolar Disorders(2022)10.1186/s40345-022-00263-7

Top 100%

0DataRank

Top 100%0 citations

Dede Greenstein, Carlos A. Zarate, Elizabeth D. Ballard, Bartholt Bloomfield-Clagett

Papers

Driven by 126 papers — median percentile 0. Top paper: “Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis”.

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Journal of Affective Disorders(2020)10.1016/j.jad.2020.09.071

N/A

10.5DataRank · unranked

405 citations

Gustavo Vázquez, Carlos A. Zarate, Anees Bahji

ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing

Translational Psychiatry(2020)10.1038/s41398-020-0842-6

N/A

4.6DataRank · unranked

240 citations

Elena Pozzi, Tiffany C. Ho, Laura S. van Velzen, Ilya M. Veer, Nils Opel +73 more

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals

Molecular Psychiatry(2020)10.1038/s41380-020-00878-1

N/A

2.2DataRank · unranked

110 citations

Jennifer W. Evans, Christoph Kraus, Peixiong Yuan, Bashkim Kadriu, Allison C. Nugent +3 more

New Methods for Assessing Rapid Changes in Suicide Risk

Frontiers in Psychiatry(2021)10.3389/fpsyt.2021.598434

N/A

2.1DataRank · unranked

61 citations

Jessica R. Gilbert, Christina Wusinich, Carlos A. Zarate, Elizabeth D. Ballard

Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment

Neuropsychopharmacology(2020)10.1038/s41386-020-0624-0

N/A

1.7DataRank · unranked

57 citations

Anahit Mkrtchian, Bashkim Kadriu, Allison C. Nugent, Carlos A. Zarate, Jennifer W. Evans +1 more

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

The International Journal of Neuropsychopharmacology(2020)10.1093/ijnp/pyaa025

N/A

1.6DataRank · unranked

62 citations

Bashkim Kadriu, Todd D. Gould, Panos Zanos, Deanna Greenstein, Jennifer W. Evans +12 more

Multilayer MEG functional connectivity as a potential marker for suicidal thoughts in major depressive disorder

NeuroImage Clinical(2020)10.1016/j.nicl.2020.102378

N/A

1.2DataRank · unranked

33 citations

Elizabeth D. Ballard, Jessica R. Gilbert, Prejaas Tewarie, Matthew J. Brookes, Carlos A. Zarate +1 more

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

American Journal of Psychiatry(2025)10.1176/appi.ajp.20240378

N/A

1.2DataRank · unranked

49 citations

Reece C. Budinich, Jordi Bonaventura, Alan F. Schatzberg, Carlos A. Zarate, Michel Michaelides +1 more

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

American Journal of Psychiatry(2021)10.1176/appi.ajp.2020.20081251

N/A

0.984DataRank · unranked

704 citations

Joshua D. Rosenblat, Charles B. Nemeroff, Gerard Sanacora, James W. Murrough, Michael Berk +20 more

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration

Translational Psychiatry(2022)10.1038/s41398-022-01941-x

N/A

0.928DataRank · unranked

32 citations

Panos Zanos, Cristan Farmer, Bashkim Kadriu, Patrick J. Morris, Jacqueline Lovett +10 more

Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals

Translational Psychiatry(2023)10.1038/s41398-023-02674-1

N/A

0.820DataRank · unranked

26 citations

Peter C.T. Hawkins, Jennifer W. Evans, Mitul A. Mehta, Carlos A. Zarate, Laith Alexander

The relationship between the HDRS insomnia items and polysomnographic (PSG) measures in individuals with treatment-resistant depression

Journal of Psychiatric Research(2022)10.1016/j.jpsychires.2022.01.022

N/A

0.815DataRank · unranked

15 citations

Cristan Farmer, Mark Oppenheimer, Tolulope B. Falodun, Lawrence T. Park, Wallace C. Duncan +2 more

Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder

The Journal of Clinical Psychiatry(2020)10.4088/jcp.20m13233

N/A

0.810DataRank · unranked

18 citations

James C. West, Catherine L. Dempsey, Kyle Possemato, Danielle Bartolanzo, Pablo A. Aliaga +4 more

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry(2011)10.1016/j.pnpbp.2011.03.019

N/A

0.789DataRank · unranked

192 citations

Nancy Diazgranados, David A. Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G. Mallinger +2 more

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression

Frontiers in Psychiatry(2021)10.3389/fpsyt.2021.673159

N/A

0.713DataRank · unranked

21 citations

Christina S. Galiano, Allison C. Nugent, Carlos A. Zarate, Jessica R. Gilbert

Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants

The International Journal of Neuropsychopharmacology(2020)10.1093/ijnp/pyaa087

N/A

0.691DataRank · unranked

99 citations

Maximillian Greenwald, Ioline D. Henter, Jessica R. Gilbert, Christoph Kraus, Lawrence T. Park +2 more

Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

Expert Opinion on Drug Safety(2022)10.1080/14740338.2022.2047928

N/A

0.644DataRank · unranked

72 citations

Carlos A. Zarate, Gustavo Vázquez, Anees Bahji

Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder

Journal of Affective Disorders(2020)10.1016/j.jad.2020.10.007

N/A

0.637DataRank · unranked

14 citations

Linnea Sepe-Forrest, Jessica R. Gilbert, Frederick W. Carver, Maura L. Furey, Carlos A. Zarate +2 more

Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts

Biological Psychiatry(2021)10.1016/j.biopsych.2021.03.015

N/A

0.626DataRank · unranked

64 citations

Paul M. Thompson, Dick J. Veltman, Elena Pozzi, Laura S. van Veltzen, Neda Jahanshad +58 more

Exome-wide association study of treatment-resistant depression suggests novel treatment targets

Scientific Reports(2023)10.1038/s41598-023-38984-z

N/A

0.605DataRank · unranked

15 citations

Teja Peddada, Christopher Song, Maame Mensah, Heejong Sung, Mani Yavi +7 more

Development of the Ketamine Side Effect Tool (KSET)

Journal of Affective Disorders(2020)10.1016/j.jad.2020.01.120

N/A

0.587DataRank · unranked

49 citations

Vanessa Dong, Verònica Gálvez, Vedran Vulovic, Donel Martin, Adam Bayes +11 more

Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials

Neuropsychopharmacology(2024)10.1038/s41386-024-02044-5

N/A

0.581DataRank · unranked

47 citations

Anna Gramser, Victoria Watzal, Carlos A. Zarate, Rupert Lanzenberger, Christoph Kraus +1 more

Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies

The Lancet Psychiatry(2023)10.1016/s2215-0366(23)00183-9

N/A

0.557DataRank · unranked

40 citations

Malcolm Matheson, Isabella Demo, Matthew J. Reid, Sharaya Matheson, Claire Twose +6 more

Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression

Translational Psychiatry(2024)10.1038/s41398-024-02956-2

N/A

0.538DataRank · unranked

16 citations

Deanna Greenstein, Philip T. Reiss, Ciprian M. Crainiceanu, Erjia Cui, Wallace C. Duncan +3 more

The impact of body mass index on the clinical features of bipolar disorder: A STEP‐BD study

Bipolar Disorders(2023)10.1111/bdi.13370

N/A

0.518DataRank · unranked

11 citations

Zhi‐De Deng, Christoph Kraus, Jenessa N. Johnston, Adam Fijtman, Ioline D. Henter +3 more

Long-term follow-up of participants in ketamine clinical trials for mood disorders

Journal of Affective Disorders(2024)10.1016/j.jad.2024.04.062

N/A

0.509DataRank · unranked

8 citations

Abigail Vogeley, Deanna Greenstein, Lauren J. Durland, Stephanie Makel, Philip R. Wang +4 more

Exploring the impact of music on response to ketamine/esketamine: A scoping review

Neuroscience & Biobehavioral Reviews(2024)10.1016/j.neubiorev.2024.105693

N/A

0.506DataRank · unranked

13 citations

Allison C. Nugent, Alicia A. Livinski, Lucinda Neely, Sara C. Johnson, Ioline D. Henter +9 more

A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801

Neurotoxicology and Teratology(2021)10.1016/j.ntt.2021.106993

N/A

0.505DataRank · unranked

28 citations

Richard Burke, Alok Sharma, Daniel C. Lynch, Leslie E. Lemke-Boutcher, Shiny Mathew +8 more

Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor

Journal of Affective Disorders(2020)10.1016/j.jad.2020.11.011

N/A

0.477DataRank · unranked

23 citations

Dede Greenstein, Bashkim Kadriu, Peixiong Yuan, Lawrence T. Park, Todd D. Gould +2 more

Potential association between suicide risk, aggression, impulsivity, and the somatosensory system

Social Cognitive and Affective Neuroscience(2024)10.1093/scan/nsae041

N/A

0.461DataRank · unranked

14 citations

Jessica R. Gilbert, Laura R. Waldman, Carlos A. Zarate, Elizabeth D. Ballard, Yoojin Lee

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder

Frontiers in Neuroscience(2023)10.3389/fnins.2023.1228455

N/A

0.442DataRank · unranked

18 citations

Alan C. Courtes, Carlos A. Zarate, Ioline D. Henter, Husseini K. Manji, Rodrigo Machado‐Vieira

A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants

Progress in Neurobiology(2021)10.1016/j.pneurobio.2021.102140

N/A

0.416DataRank · unranked

15 citations

Roosa Saarreharju, Ioline D. Henter, Carlos A. Zarate, Samuel Kohtala, Tomi Rantamäki +1 more

Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task

Psychological Medicine(2023)10.1017/s0033291723003331

N/A

0.379DataRank · unranked

8 citations

Jessica R. Gilbert, Paloma K. Zabala, Laura R. Waldman, Carlos A. Zarate, Elizabeth D. Ballard +1 more

Brain correlates of suicide attempt in 18,925 participants across 18 international cohorts

medRxiv(2020)10.1101/2020.05.06.20090191

N/A

0.345DataRank · unranked

9 citations

Paul M. Thompson, Dick J. Veltman, Elena Pozzi, Laura S. van Veltzen, Neda Jahanshad +59 more

REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression

Neuropsychopharmacology(2025)10.1038/s41386-025-02066-7

N/A

0.328DataRank · unranked

6 citations

Wallace C. Duncan, Qiaoping Yuan, Philip R. Wang, Hamidreza Jamalabadi, Lutz Leistritz +5 more

Assessment of complement cascade components in patients with major depressive disorder

Brain Behavior and Immunity(2025)10.1016/j.bbi.2025.03.009

N/A

0.312DataRank · unranked

7 citations

Dede Greenstein, Ashutosh Tripathi, Alona Bartosh, Peixiong Yuan, Carlos A. Zarate +2 more

Glutamate modulators and beyond: A neuroscience revolution in the making

European Neuropsychopharmacology(2021)10.1016/j.euroneuro.2021.09.005

N/A

0.312DataRank · unranked

7 citations

Carlos A. Zarate

Clinical and electrophysiological correlates of hopelessness in the context of suicide risk✰

European Neuropsychopharmacology(2024)10.1016/j.euroneuro.2023.12.002

N/A

0.308DataRank · unranked

6 citations

Roshni P. Nischal, Courtney R. Burton, Deanna Greenstein, Grace Anderson, Laura R. Waldman +3 more

κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine

Journal of Clinical Psychopharmacology(2023)10.1097/jcp.0000000000001663

N/A

0.284DataRank · unranked

4 citations

Gustavo C. Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N. Johnston, Lawrence T. Park +4 more

Clinical Trials With Suicidal Individuals Can Be Conducted Safely

The Journal of Clinical Psychiatry(2020)10.4088/jcp.20l13353

N/A

0.276DataRank · unranked

3 citations

Lawrence T. Park, Maryland Pao, Carlos A. Zarate, Elizabeth D. Ballard

Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder

The Canadian Journal of Psychiatry(2021)10.1177/07067437211004023

N/A

0.269DataRank · unranked

5 citations

Carlos A. Zarate

Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial

npj Digital Medicine(2025)10.1038/s41746-025-02143-7

N/A

0.269DataRank · unranked

5 citations

Bessi Qorri, Mike Tsay, Christian Cumbaa, Paul Leonczyk, Larry Alphs +4 more

Clinical indicators of the suicide crisis and response to ketamine

Journal of Affective Disorders(2024)10.1016/j.jad.2024.11.080

N/A

0.241DataRank · unranked

4 citations

Lucinda Neely, Laura Tesler Waldman, Dede Greenstein, Carlos A. Zarate, Elizabeth D. Ballard

An exploration of actigraphy in the context of ketamine and treatment‐resistant depression

International Journal of Methods in Psychiatric Research(2023)10.1002/mpr.1984

N/A

0.214DataRank · unranked

3 citations

Wallace C. Duncan, Dede Greenstein, Gavi Shandler, Carlos A. Zarate, Jennifer W. Evans +1 more

Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model

Molecular Psychiatry(2025)10.1038/s41380-025-03273-w

N/A

0.208DataRank · unranked

3 citations

Tracy Erwin-Grabner, Ling‐Li Zeng, Christopher R. K. Ching, André Alemán, Alyssa R. Amod +82 more

Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study

Translational Psychiatry(2025)10.1038/s41398-025-03724-6

N/A

0.165DataRank · unranked

2 citations

Peixiong Yuan, Bashkim Kadriu, Nirmala Akula, Brandi Quintanilla, Shiyong Peng +9 more

Classification of Major Depressive Disorder Using Vertex-Wise Brain Sulcal Depth, Curvature, and Thickness with a Deep and a Shallow Learning Model

arXiv (Cornell University)(2023)10.48550/arxiv.2311.11046

N/A

0.165DataRank · unranked

2 citations

Tracy Erwin-Grabner, Ling‐Li Zeng, Christopher R. K. Ching, André Alemán, Alyssa R. Amod +82 more

Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depression

Journal of Affective Disorders(2025)10.1016/j.jad.2025.119448

N/A

0.104DataRank · unranked

1 citations

Nadia S. Hejazi, Allison C. Nugent, Jessica R. Gilbert, Lutz Leistritz, Martin Walter +4 more

Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”

Molecular Psychiatry(2024)10.1038/s41380-024-02864-3

N/A

0.104DataRank · unranked

1 citations

Paulo Alexandre de Oliveira, Nil Casajuana-Martín, César Quiroz, Reece C. Budinich, Rana Rais +15 more

Ketamine in neuropsychiatric disorders: an update

Neuropsychopharmacology(2023)10.1038/s41386-023-01632-1

N/A

0DataRank · unranked

99 citations

Bashkim Kadriu, Christoph Kraus, Ioline D. Henter, Carlos A. Zarate, Jenessa N. Johnston

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment

Neuropharmacology(2023)10.1016/j.neuropharm.2023.109422

N/A

0DataRank · unranked

65 citations

Bashkim Kadriu, Josh Allen, Jessica R. Gilbert, Ioline D. Henter, Carlos A. Zarate +1 more

Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile

Drug Discovery Today(2023)10.1016/j.drudis.2023.103518

N/A

0DataRank · unranked

64 citations

Maximillian Greenwald, Ioline D. Henter, Christoph Kraus, Anahit Mkrtchian, Neil G. Clark +5 more

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database

Journal of Affective Disorders(2023)10.1016/j.jad.2023.05.042

N/A

0DataRank · unranked

42 citations

Alexander Kautzky, Victoria Watzal, Anna Gramser, Bashkim Kadriu, Zhi‐De Deng +11 more

The role of dissociation in ketamine’s antidepressant effects

Nature Communications(2020)10.1038/s41467-020-20190-4

N/A

0DataRank · unranked

214 citations

Carlos A. Zarate, Elizabeth D. Ballard

Functional MRI markers for treatment-resistant depression: Insights and challenges

Progress in brain research(2023)10.1016/bs.pbr.2023.04.001

N/A

0DataRank · unranked

17 citations

Jennifer W. Evans, Claire Punturieri, Sara C. Johnson, Carlos A. Zarate, Vasileia Kotoula

Toward objective characterizations of suicide risk: A narrative review of laboratory-based cognitive and behavioral tasks

Neuroscience & Biobehavioral Reviews(2023)10.1016/j.neubiorev.2023.105361

N/A

0DataRank · unranked

11 citations

Paloma K. Zabala, Carlos A. Zarate, Elizabeth D. Ballard, Steven J. Lamontagne

Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion

iScience(2023)10.1016/j.isci.2023.108527

N/A

0DataRank · unranked

11 citations

Cristan Farmer, Mani Yavi, Bashkim Kadriu, Min Zhu, JINSHUI FAN +13 more

Assessing geographic disparities in mental health research participation

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107244

N/A

0DataRank · unranked

9 citations

Elizabeth Friberg, Lawrence T. Park, Regina DeGennaro, Ivora Hinton, Carlos A. Zarate +1 more

An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression

Journal of Clinical Psychopharmacology(2023)10.1097/jcp.0000000000001738

N/A

0DataRank · unranked

6 citations

Mani Yavi, Holim Lee, Yasmine Kotb, Lorie Shora, Lawrence T. Park +2 more

Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer’s disease

Brain(2024)10.1093/brain/awae234

N/A

0DataRank · unranked

50 citations

Quentin Finn, Paolo Zanotti‐Fregonara, Meixiang Yu, Alireza Faridar, Mohammad Obadah Nakawah +8 more

Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures

Scientific Reports(2024)10.1038/s41598-023-47934-8

N/A

0DataRank · unranked

35 citations

Tracy Erwin-Grabner, Moji Aghajani, André Alemán, Alyssa R. Amod, Zeynep Başgöze +61 more

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3391

N/A

0DataRank · unranked

34 citations

Jeffrey T. Guptill, Michelle Mack, Marni Peterson, Stephen J. Byard, Robert J. Twieg +36 more

Associations between hypothalamic-pituitary-adrenal (HPA) axis hormone levels, major depression features and antidepressant effects of ketamine

Journal of Affective Disorders(2024)10.1016/j.jad.2024.12.036

N/A

0DataRank · unranked

24 citations

Cristan Farmer, Gustavo C. Medeiros, Peixiong Yuan, Jenessa N. Johnston, Bashkim Kadriu +3 more

Esketamine in depression: putative biomarkers from clinical research

European Archives of Psychiatry and Clinical Neuroscience(2024)10.1007/s00406-024-01865-1

N/A

0DataRank · unranked

18 citations

Carlos A. Zarate, Mark D. Kvarta, Jenessa N. Johnston

Ketamine’s mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine’s antidepressant effects?

Molecular Psychiatry(2024)10.1038/s41380-024-02507-7

N/A

0DataRank · unranked

17 citations

Carlos A. Zarate, Anilkumar Pillai, Brandi Quintanilla

Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic intervention

Psychiatry and Clinical Neurosciences(2024)10.1111/pcn.13703

N/A

0DataRank · unranked

16 citations

Carlos A. Zarate, Joseph G. Verbalis, Hiroe Hu

Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders

Biological Psychiatry(2024)10.1016/j.biopsych.2024.09.008

N/A

0DataRank · unranked

15 citations

Andria Michael, Markos Apostolakis, Elmar Mammadov, Angeliki Mitka, Maria A Kalatta +8 more

Sleep Delta power, age, and sex effects in treatment-resistant depression

Journal of Psychiatric Research(2024)10.1016/j.jpsychires.2024.04.028

N/A

0DataRank · unranked

13 citations

Wallace C. Duncan, Mina Kheirkhah, Amanda Kowalczyk, Brady A. Riedner, Mark Oppenheimer +6 more

Entactogen Effects of Ketamine: A Reverse-Translational Study

American Journal of Psychiatry(2024)10.1176/appi.ajp.20230980

N/A

0DataRank · unranked

12 citations

Dede Greenstein, Olivia L. Hutchinson, Carlos A. Zarate, Todd D. Gould, Evan Hess

Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers

Scientific Reports(2024)10.1038/s41598-024-54370-9

N/A

0DataRank · unranked

9 citations

Morgan C. Graves, Allison C. Nugent, Carlos A. Zarate, Jennifer W. Evans

Psychological state at the time of psychiatric genetic counseling impacts patient empowerment: A pre–post analysis

Journal of Genetic Counseling(2024)10.1002/jgc4.1949

N/A

0DataRank · unranked

3 citations

Colleen Jodarski, Michael Setzer, Katie L. Lewis, Jia Yan, Sophie Byers +7 more

Review: Suicide and its relationship to aggression and impulsivity

Cognitive Affective & Behavioral Neuroscience(2025)10.3758/s13415-025-01321-0

N/A

0DataRank · unranked

6 citations

Jessica R. Gilbert, Laura R. Waldman, Carlos A. Zarate, Elizabeth D. Ballard, Yoojin Lee

Temporal dynamics of affective scene processing in the healthy adult human brain

Neuroscience & Biobehavioral Reviews(2025)10.1016/j.neubiorev.2025.106003

N/A

0DataRank · unranked

3 citations

Alicia A. Livinski, Shahaboddin Dabaghi Varnosfaderani, Nooshin Javaheripour, Hamidreza Jamalabadi, Vasileia Kotoula +8 more

Blood-based biomarkers in ketamine treatment: A blueprint for translational drug development in mood disorders

Journal of Affective Disorders(2025)10.1016/j.jad.2025.120016

N/A

0DataRank · unranked

2 citations

Gregory Jones, Ioline D. Henter, Lokesh Shahani, Gabriel R. Fries, Mário F. Juruena +4 more

Bifunctional Modulation of NMDA and Opioid Receptors in Ketamine Reinforcement and Misuse: Implications for Substance Use Disorder Treatment

Biological Psychiatry(2025)10.1016/j.biopsych.2025.11.021

N/A

0DataRank · unranked

2 citations

Ingrid Schoenborn, Peter Manza, Alan F. Schatzberg, Carlos A. Zarate, Jordi Bonaventura +2 more

Can ketamine and other glutamate receptor modulators be considered entactogens?

Psychiatry Research(2025)10.1016/j.psychres.2025.116513

N/A

0DataRank · unranked

2 citations

Alaina N Tillman, Miyu Fujita, Mayu Yoshikawa, Elizabeth D. Ballard, Yoojin Lee +2 more

Thyroid-stimulating hormone is associated with differential antidepressant and anti-anhedonic response to ketamine in bipolar depression but not major depressive disorder

Journal of Affective Disorders(2025)10.1016/j.jad.2025.120780

N/A

0DataRank · unranked

0 citations

Adam Fijtman, Nefize Yalın, Mark D. Kvarta, Philip R. Wang, Mani Yavi +3 more

Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

Molecular Psychiatry(2023)10.1038/s41380-023-02353-z

N/A

0DataRank · unranked

27 citations

Paulo Alexandre de Oliveira, Nil Casajuana-Martín, César Quiroz, Reece C. Budinich, Rana Rais +15 more

Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

Neuropsychopharmacology(2020)10.1038/s41386-020-0663-6

N/A

0DataRank · unranked

83 citations

Jessica R. Gilbert, Ruin Moaddel, Jomy George, Lilian Adeojo, Jacqueline Lovett +7 more

Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation

Pharmacology Biochemistry and Behavior(2020)10.1016/j.pbb.2020.172856

N/A

0DataRank · unranked

72 citations

Carlos A. Zarate, Jessica R. Gilbert

Metacognition and emotion – How accurate perception of own biases relates to positive feelings and hedonic capacity

Consciousness and Cognition(2020)10.1016/j.concog.2020.102936

N/A

0DataRank · unranked

22 citations

Hanna Brycz, Paweł Kleka, Agnieszka Fanslau, Carlos A. Zarate, Allison C. Nugent +1 more

Not So Fast

The Journal of Clinical Psychiatry(2020)10.4088/jcp.19ac13138

N/A

0DataRank · unranked

15 citations

Zhi‐De Deng, Christoph Kraus, Ioline D. Henter, Sarah H. Lisanby, Carlos A. Zarate +1 more

The effects of ketamine on typical and atypical depressive symptoms

Acta Psychiatrica Scandinavica(2020)10.1111/acps.13216

N/A

0DataRank · unranked

23 citations

David A. Luckenbaugh, Steven Pennybaker, Matthew Hopkins, Ioline D. Henter, Marc S. Lener +4 more

Network Changes in Insula and Amygdala Connectivity Accompany Implicit Suicidal Associations

Frontiers in Psychiatry(2020)10.3389/fpsyt.2020.577628

N/A

0DataRank · unranked

20 citations

Jessica R. Gilbert, Jessica Fields, Allison C. Nugent, Carlos A. Zarate, Elizabeth D. Ballard

Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner

European Neuropsychopharmacology(2020)10.1016/j.euroneuro.2020.01.001

N/A

0DataRank · unranked

44 citations

Betina Elfving, Ali H. Rafati, Monireh Mansouri, Carlos A. Zarate, Aleksander A. Mathé +2 more

Neurobiological biomarkers of response to ketamine

Advances in pharmacology(2020)10.1016/bs.apha.2020.05.003

N/A

0DataRank · unranked

35 citations

Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus, Carlos A. Zarate +1 more

Can ‘floating’ predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression

Journal of Psychiatric Research(2020)10.1016/j.jpsychires.2020.06.012

N/A

0DataRank · unranked

33 citations

Grace W. Cavanaugh, Dede Greenstein, Christoph Kraus, Bashkim Kadriu, Lawrence Park +2 more

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder

Frontiers in Psychiatry(2020)10.3389/fpsyt.2020.00519

N/A

0DataRank · unranked

29 citations

Elizabeth D. Ballard, Jessica R. Gilbert, Prejaas Tewarie, Matthew J. Brookes, Carlos A. Zarate +1 more

Ketamine: a new chapter in antidepressant development

Brazilian Journal of Psychiatry(2020)10.1590/1516-4446-2020-1000

N/A

0DataRank · unranked

8 citations

Carlos A. Zarate

Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse?

Journal of Affective Disorders(2020)10.1016/j.jad.2020.12.069

N/A

0DataRank · unranked

4 citations

Gustavo Vázquez, Carlos A. Zarate, Anees Bahji

Biologically plausible models of neural dynamics for rapid-acting antidepressant interventions

Neuropsychopharmacology(2020)10.1038/s41386-020-00804-7

N/A

0DataRank · unranked

0 citations

Carlos A. Zarate, Jessica R. Gilbert

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2020)10.17615/wfvq-kk18

N/A

0DataRank · unranked

0 citations

Peixiong Yuan, Yuhong Fang, Cheryl L. Mayo, Xi‐Ping Huang, Todd D. Gould +15 more

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Molecular Psychiatry(2021)10.1038/s41380-021-01093-2

N/A

0DataRank · unranked

266 citations

Sherry Lam, Meghan L. Carlton, Matthew A. Boehm, Juan L. Gomez, Óscar Solís +9 more

Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses

European Neuropsychopharmacology(2021)10.1016/j.euroneuro.2021.10.003

N/A

0DataRank · unranked

138 citations

Mauricio Tohen, Carlos A. Zarate, Konstantinos Ν. Fountoulakis

Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

CNS Drugs(2021)10.1007/s40263-021-00816-x

N/A

0DataRank · unranked

136 citations

Lawrence T. Park, Carlos A. Zarate, Ioline D. Henter

Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications

Pharmacological Reviews(2021)10.1124/pharmrev.120.000149

N/A

0DataRank · unranked

94 citations

Panos Zanos, Lace M. Riggs, Polymnia Georgiou, Sarah M. Clark, Patrick J. Morris +6 more

Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road

Drug Discovery Today(2021)10.1016/j.drudis.2021.07.027

N/A

0DataRank · unranked

58 citations

Laura Musazzi, Jenessa N. Johnston, Lisa E. Kalynchuk, Héctor J. Caruncho, Maurizio Popoli +2 more

Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research

The International Journal of Neuropsychopharmacology(2021)10.1093/ijnp/pyab083

N/A

0DataRank · unranked

53 citations

Darcy Campbell, Héctor J. Caruncho, Ioline D. Henter, Elizabeth D. Ballard, Carlos A. Zarate +1 more

Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial

Translational Psychiatry(2021)10.1038/s41398-021-01318-6

N/A

0DataRank · unranked

34 citations

Christoph Kraus, Ruth M. Pfeiffer, René Seiger, Dan Rujescu, Carlos A. Zarate +4 more

Key considerations in the pharmacological management of treatment-resistant depression

Expert Opinion on Pharmacotherapy(2021)10.1080/14656566.2021.1951225

N/A

0DataRank · unranked

14 citations

Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate, Mani Yavi

Clinical trials for rapid changes in suicidal ideation: Lessons from ketamine

Suicide and Life-Threatening Behavior(2021)10.1111/sltb.12663

N/A

0DataRank · unranked

11 citations

Jessica Fields, Cristan Farmer, Carlos A. Zarate, Elizabeth D. Ballard

The mental health impact of contact with COVID-19 patients on healthcare workers in the United States

Psychiatry Research(2021)10.1016/j.psychres.2021.114359

N/A

0DataRank · unranked

9 citations

Elizabeth D. Ballard, Grace Anderson, Dede Greenstein, Grace W. Cavanaugh, Elspeth Dwyer +5 more

The Dynamic Relationship Between Alpha and Beta Power and Next-Day Suicidal Ideation in Individuals With Treatment-Resistant Depression

Biological Psychiatry Global Open Science(2021)10.1016/j.bpsgos.2021.07.003

N/A

0DataRank · unranked

2 citations

Deanna Greenstein, Wallace C. Duncan, Nadia S. Hejazi, Jessica L. Gerner, Carlos A. Zarate +1 more

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

Translational Psychiatry(2021)10.1038/s41398-021-01442-3

N/A

0DataRank · unranked

1 citations

Robert Leech, Steven Williams, Carlos A. Zarate, Rosalyn Moran, Jessica R. Gilbert +1 more

Ketamine and attentional bias to threat: dynamic causal modeling of magnetoencephalographic connectivity in treatment-resistant depression

medRxiv(2021)10.1101/2021.02.22.21252247

N/A

0DataRank · unranked

0 citations

Christina S. Galiano, Allison C. Nugent, Carlos A. Zarate, Jessica R. Gilbert

Reply to: “Letter to the Editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of Lightnessare not the same – A comment on Acevedo-Diaz et al.” (Jpsychiatrres-D-21-00121)

Journal of Psychiatric Research(2021)10.1016/j.jpsychires.2021.03.018

N/A

0DataRank · unranked

0 citations

Maximillian Greenwald, Grace W. Cavanaugh, Dede Greenstein, Christoph Kraus, Bashkim Kadriu +3 more

Ketamine treatment for depression: a review

Discover Mental Health(2022)10.1007/s44192-022-00012-3

N/A

0DataRank · unranked

151 citations

Holim Lee, Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate, Mani Yavi

Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

Nature Neuroscience(2022)10.1038/s41593-022-01146-x

N/A

0DataRank · unranked

136 citations

Panos Zanos, Ta-Chung M. Mou, Xiaoxian An, Danielle M. Gerhard, Dilyan I. Dryanovski +17 more

Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability

Biological Psychiatry(2022)10.1016/j.biopsych.2022.12.019

N/A

0DataRank · unranked

53 citations

Meghan L. Carlton, Tommaso Di Ianni, Emilya Ventriglia, Arianna Rizzo, Juan L. Gomez +7 more

A Predictive Coding Framework for Understanding Major Depression

Frontiers in Human Neuroscience(2022)10.3389/fnhum.2022.787495

N/A

0DataRank · unranked

36 citations

Christina Wusinich, Carlos A. Zarate, Jessica R. Gilbert

The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry

Journal of Affective Disorders(2022)10.1016/j.jad.2022.04.020

N/A

0DataRank · unranked

21 citations

Brooke Short, Carlos A. Zarate, Lawrence Park, James W. Murrough, Declan M. McLoughlin +13 more

Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search

Molecular Psychiatry(2022)10.1038/s41380-022-01673-w

N/A

0DataRank · unranked

45 citations

Juan L. Gomez, Meghan L. Carlton, Sherry Lam, Marta Sánchez‐Soto, Patrick J. Morris +9 more

Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression

Journal of Affective Disorders(2022)10.1016/j.jad.2022.06.025

N/A

0DataRank · unranked

18 citations

Jessica L. Gerner, Courtney R. Burton, Allison C. Nugent, Carlos A. Zarate, Elizabeth D. Ballard +1 more

Prospective association of psychological pain and hopelessness with suicidal thoughts

Journal of Affective Disorders(2022)10.1016/j.jad.2022.04.033

N/A

0DataRank · unranked

17 citations

Cristan Farmer, Jessica L. Gerner, Bartholt Bloomfield-Clagett, Lawrence T. Park, Carlos A. Zarate +1 more

Predictors of suicidal ideation trajectories in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study

Journal of Psychiatric Research(2022)10.1016/j.jpsychires.2022.01.027

N/A

0DataRank · unranked

15 citations

Dede Greenstein, Joseph M. Kush, Rashelle J. Musci, Carlos A. Zarate, Elizabeth D. Ballard +1 more

Transcriptional Activation, Deactivation and Rebound Patterns in Cortex, Hippocampus and Amygdala in Response to Ketamine Infusion in Rats

Frontiers in Molecular Neuroscience(2022)10.3389/fnmol.2022.892345

N/A

0DataRank · unranked

12 citations

Matthew R. Sapio, Fernando A. Vazquez, Dragan Maric, Amelia J. Loydpierson, Wenting Ma +4 more

Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics

Current topics in behavioral neurosciences(2022)10.1007/7854_2022_313

N/A

0DataRank · unranked

11 citations

Johan Saelens, Bashkim Kadriu, Carlos A. Zarate, Christoph Kraus, Marina Kojic

6-O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo

Molecular Imaging and Biology(2022)10.1007/s11307-022-01767-5

N/A

0DataRank · unranked

9 citations

Emilya Ventriglia, Juan L. Gomez, Reece C. Budinich, János Marton, Gjermund Henriksen +7 more

A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine

The International Journal of Neuropsychopharmacology(2022)10.1093/ijnp/pyac055

N/A

0DataRank · unranked

8 citations

Elizabeth D. Ballard, Deanna Greenstein, Samuel T. Wilkinson, Michael F. Grunebaum, James W. Murrough +6 more

Authors’ Reply to Pappagallo et al.: Comment on “Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status”

CNS Drugs(2022)10.1007/s40263-021-00892-z

N/A

0DataRank · unranked

6 citations

Lawrence T. Park, Carlos A. Zarate, Ioline D. Henter

Time will tell. Reply to “Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.” by Chen et al.

Molecular Psychiatry(2022)10.1038/s41380-022-01480-3

N/A

0DataRank · unranked

6 citations

Sherry Lam, Meghan L. Carlton, Matthew A. Boehm, Juan L. Gomez, Óscar Solís +9 more

Roles of Strong Scalar Couplings in Maximizing Glutamate, Glutamine and Glutathione Pseudo Singlets at 7 Tesla

Frontiers in Physics(2022)10.3389/fphy.2022.927162

N/A

0DataRank · unranked

2 citations

Jennifer W. Evans, Courtney R. Burton, Jyoti Tomar, Maria Ferraris Araneta, Carlos A. Zarate +2 more

Experimenter sex modulates mouse biobehavioural and pharmacological responses

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.09.475572

N/A

0DataRank · unranked

2 citations

Panos Zanos, Ta-Chung M. Mou, Xiaoxian An, Danielle M. Gerhard, Dilyan I. Dryanovski +17 more

The association between variability, intensity, and persistence of suicidal ideation and prospective suicidal behavior in the systematic treatment enhancement program for bipolar disorder (STEP-BD) study

International Journal of Bipolar Disorders(2022)10.1186/s40345-022-00263-7

Top 100%

0DataRank

Top 100%0 citations

Dede Greenstein, Carlos A. Zarate, Elizabeth D. Ballard, Bartholt Bloomfield-Clagett

NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine

Journal of Neuroscience(2023)10.1523/jneurosci.1316-22.2022

N/A

0DataRank · unranked

109 citations

Kyle A. Brown, Polymnia Georgiou, Peixiong Yuan, Carlos A. Zarate, Scott M. Thompson +2 more

The antidepressant actions of ketamine and its enantiomers

Pharmacology & Therapeutics(2023)10.1016/j.pharmthera.2023.108431

N/A

0DataRank · unranked

106 citations

Ioline D. Henter, Carlos A. Zarate, Jenessa N. Johnston

Carlos A. Zarate

Indexed papers

Top data-sharing exemplar

Papers